证券代码：688255 证券简称：凯尔达 公告编号：2025-046 杭州凯尔达焊接机器人股份有限公司 第四届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 杭州凯尔达焊接机器人股份有限公司（以下简称"公司"）第四届董事会第 十一次会议于 2025 年 9 月 16 日以现场结合通讯方式在公司会议室召开。经与会 董事一致同意豁免本次会议的通知时限。会议应出席董事 9 人，实际出席董事 8 人，董事足立恭雄先生委托董事侯润石先生代为出席并表决，公司全体高级管理 人员列席会议，会议由董事长侯润石先生召集主持。本次会议的召集、召开及表 决程序符合《中华人民共和国公司法》（以下简称"《公司法》"）等法律、行 政法规、部门规章和《公司章程》的有关规定。 二、董事会会议审议表决情况 表决结果：同意 9 票，反对 0 票，弃权 0 票。 2、审议通过了《关于确认审计委员会成员及召集人的议案》 根据《公司法》及《公司章程》的有关规定，董事会同意确认江乾坤先生、 倪仲夫先生、王仕凯先生为公 ...

Company Overview - Kaierda (SH 688255) announced the convening of its 11th meeting of the 4th Board of Directors on September 16, 2025, to review the proposal for establishing a "Management System for the Departure of Directors and Senior Management" [1] Financial Performance - For the fiscal year 2024, Kaierda's revenue composition is as follows: Industrial Robotics accounts for 69.16%, Industrial Welding Equipment for 23.8%, Other Businesses for 5.16%, and Other Industries for 1.87% [1] Market Position - As of the report, Kaierda's market capitalization stands at 4.2 billion yuan [1]

Group 1 - The stock price of Kailida increased by 5.19% to 37.50 CNY per share, with a trading volume of 59.04 million CNY and a turnover rate of 1.47%, resulting in a total market capitalization of 4.12 billion CNY [1] - Kailida specializes in the research, production, and sales of welding robots and industrial welding equipment, with its main business revenue composition being 68.86% from industrial robots, 23.78% from industrial welding equipment, and 7.36% from other sources [1] Group 2 - The Huaxia CSI Robotics ETF (562500) entered the top ten circulating shareholders of Kailida in the second quarter, holding 1.49 million shares, which accounts for 1.36% of the circulating shares, resulting in an estimated floating profit of approximately 2.76 million CNY [2] - The Huaxia CSI Robotics ETF has a total scale of 14.47 billion CNY and has achieved a year-to-date return of 33.79%, ranking 1246 out of 4222 in its category, with a one-year return of 88.73%, ranking 740 out of 3804 [2]

Core Viewpoint - The financial performance and trading activity of Kailida Robotics indicate a mixed outlook, with a decline in revenue and net profit, while financing activities remain at a relatively high level [1][2]. Group 1: Financial Performance - As of June 30, 2025, Kailida reported a revenue of 316 million yuan, a year-on-year decrease of 1.81% [2]. - The net profit attributable to shareholders was 2.365 million yuan, reflecting a significant year-on-year decline of 89.94% [2]. - Cumulative cash dividends since the company's A-share listing amount to 107 million yuan, with 67.51 million yuan distributed over the past three years [2]. Group 2: Shareholder and Market Activity - As of September 15, 2023, Kailida's stock price increased by 1.05%, with a trading volume of 92.748 million yuan [1]. - The financing buy-in on that day was 16.272 million yuan, while the financing repayment was 15.606 million yuan, resulting in a net financing buy-in of 666,800 yuan [1]. - The total financing and securities balance reached 177 million yuan, accounting for 4.52% of the circulating market value, which is above the 70th percentile of the past year [1]. Group 3: Shareholder Structure - As of June 30, 2025, the number of Kailida shareholders was 7,278, a decrease of 14.18% from the previous period [2]. - The average number of circulating shares per shareholder increased by 82.61% to 15,094 shares [2]. - Among the top ten circulating shareholders, Huaxia CSI Robotics ETF is the fifth largest, holding 1.4928 million shares as a new shareholder [2].

证券日报网讯 9月15日晚间，凯尔达发布公告称，控股子公司杭州凯维力传感科技有限公司近期获得1 项国家知识产权局颁发的发明专利证书，专利名称为"可自校准的SOI基MEMS三维力传感器及其制备工 艺"。 （文章来源：证券日报） ...

Group 1 - Yihau New Materials plans to reduce its shareholding by up to 1% of the company's total shares, amounting to 165,500 shares, due to personal funding needs [1] - Fuxing Pharmaceutical's subsidiary has received approval for a new indication for its drug, which is used in the treatment of certain types of breast cancer [1][2] - Shantui Co. has submitted its H-share issuance application to the China Securities Regulatory Commission, which has been accepted [3] Group 2 - Sierte's chairman plans to increase his shareholding by an amount between 3 million to 6 million yuan [4] - Borui Pharmaceutical's BGM0504 tablet has received approval for clinical trials in overweight and obese adults [5] - Ganyue Expressway reported vehicle toll service revenue of 349 million yuan for August [6] Group 3 - Chip Microelectronics has submitted its H-share issuance application to the China Securities Regulatory Commission, which has been accepted [7] - Lingrui Pharmaceutical's director plans to reduce his shareholding by up to 200,000 shares, representing 0.0353% of the total shares [8] - Jiahu Energy has adjusted its share repurchase price limit to 11.63 yuan per share [10] Group 4 - Spring Airlines reported a year-on-year increase of 12.23% in passenger turnover for August [11] - Kaida has received an invention patent for a self-calibrating sensor technology [12] - Chuanheng Co. has obtained a new utility model patent aimed at improving industrial waste utilization [14] Group 5 - Huashi Technology received a government subsidy of 2.21 million yuan, accounting for 22.71% of its latest audited net profit [15] - Shanghai Pharmaceuticals' controlling shareholder plans to increase its H-share holdings by up to 74 million shares [16] - Hongrun Construction has won a bid for a significant segment of the Shanghai Metro Line 21 project, valued at 126 million yuan [18] Group 6 - Sanfangxiang plans to invest 100 million yuan to establish a wholly-owned subsidiary focused on green technology [19] - Lao Fengxiang's subsidiaries plan to jointly invest in luxury goods sales and gold refining companies [20][21] - China Eastern Airlines reported an 8.72% year-on-year increase in passenger turnover for August [22] Group 7 - Inner Mongolia First Machinery has signed a railway freight car procurement contract worth 186 million yuan [22] - Jiuqiang Bio has received five invention patents related to diagnostic reagents [24] - Longmag Technology plans to invest 210 million yuan in its second phase project in Vietnam [25] Group 8 - Galaxy Magnetics plans to acquire 100% equity of Kyoto Longtai, with its stock suspended for trading [26] - Jinlong Co.'s controlling shareholder will have 30 million shares auctioned [27] - Haishi Co.'s controlling shareholder has released the pledge on 29.97 million shares [28] Group 9 - Qiu Tianwei plans to reduce its shareholding by up to 1.17% of the total shares [29] - Xiaocheng Technology's directors plan to reduce their shareholding by a total of 0.08% [30] - Victory Co. reported that Sunshine Life Insurance has reduced its shareholding by 4.4 million shares [31] Group 10 - Xindong Technology plans to distribute a cash dividend of 0.156 yuan per share [32] - Huaqin Technology plans to distribute a cash dividend of 0.13 yuan per share [33] - Kexing Pharmaceutical's controlling shareholder intends to transfer 5% of the company's shares [35] Group 11 - Guojin Securities has completed the repayment of its second short-term financing bond for 1.0205 billion yuan [38] - Chunhui Intelligent Control's application for asset acquisition has been accepted by the Shenzhen Stock Exchange [39] - Chaohongji has submitted its H-share issuance application to the Hong Kong Stock Exchange [40] Group 12 - Tianyue Advanced has fully exercised its over-allotment option, involving 716,180 H-shares [40] - Chengfeng Technology's vice president has resigned due to internal adjustments [41] - Yingpais plans to establish a 100 million yuan technology sports industry investment fund [43]

Core Viewpoint - The company Kailda (688255.SH) has recently received an invention patent certificate from the National Intellectual Property Administration, which reflects and extends its sensor technology [1] Group 1: Patent Acquisition - The invention patent obtained is a significant representation of the company's sensor technology [1] - This patent acquisition will not have a major impact on the company's recent operations but is beneficial for enhancing the company's intellectual property protection system [1] Group 2: Competitive Advantage - The patent will help the company leverage its proprietary technology advantages, promote technological innovation, and enhance its core competitiveness [1]

人民财讯9月15日电，凯尔达(688255)9月15日晚间公告，公司控股子公司杭州凯维力传感科技有限公司 于近期收到1项国家知识产权局颁发的发明专利证书，发明专利名称为可自校准的SOI基MEMS三维力 传感器及其制备工艺。 ...

杭州凯尔达焊接机器人股份有限公司（以下简称"公司"）控股子公司杭州 凯维力传感科技有限公司于近期收到 1 项国家知识产权局颁发的发明专利证书， 具体如下： | 发明专利名称 | | | 专利号 | 专利 | | 授权 | 专利权人 | 专利期限 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 申请日 | | 公告日 | | | | 可 自 准 | 校 | 的 | | | | | | | | SOI 基 MEMS | | | ZL 2023 1 | 2023 年 | 05 | 2025年08月 | 杭州凯维力传 | 20 年（自申 | | 三维力传感器 | | | 0614318.8 | 月 29 | 日 | 26 日 | 感科技有限公 司 | 请日起算） | | 及其制备工艺 | | | | | | | | | 上述发明专利的取得是公司重要技术之传感器技术的体现和延伸。本次发明 专利的获得不会对公司近期经营产生重大影响，但有利于进一步完善公司知识产 权保护体系，发挥自主知识产权的技术优势，促进技术创新，从而提升公司核心 竞 ...

Group 1 - The company has recently received a patent certificate from the United States Patent and Trademark Office for an invention related to its core technology of "motion control technology" [1] - The acquisition of this patent will not have a significant impact on the company's recent operations but will enhance its intellectual property protection system and promote technological innovation [1] - This development is expected to strengthen the company's core competitiveness through the utilization of its proprietary technology [1]